Skip to main content
Premium Trial:

Request an Annual Quote

Greg Weaver, Henry Costantino, Paul Johnson

Premium
Scolr Pharma said this week that it has appointed Greg Weaver to its board of directors.
 
Weaver is currently CFO of Talyst, a provider of automated pharmacy solutions. He was previously CFO of Sirna Therapeutics.
 

 
Nastech Pharmaceutical said last week that it has promoted Henry Costantino to CSO of delivery, following the resignation of former CSO Paul Johnson.
 
Costantino previously served as director of formulations at Nastech and was recently promoted to vice president of pharmaceutical research and development. Before Nastech, he worked at Alkermes and Genentech.
 
He holds BS and MS degrees from Johns Hopkins University, and a PhD in chemical engineering from the Massachusetts Institute of Technology.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.